Fiduciary Family Office’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,333
Closed -$375K 191
2026
Q1
$375K Sell
4,333
-4,069
-48% -$390K 0.11% 134
2025
Q4
$807K Sell
8,402
-1,482
-15% -$144K 0.23% 78
2025
Q3
$941K Buy
9,884
+1,110
+13% +$102K 0.27% 75
2025
Q2
$765K Buy
8,774
+490
+6% +$41.6K 0.25% 82
2025
Q1
$744K Buy
+8,284
New +$741K 0.25% 89
2024
Q4
Sell
-7,463
Closed -$672K 184
2024
Q3
$672K Buy
7,463
+1,763
+31% +$148K 0.22% 96
2024
Q2
$449K Buy
5,700
+559
+11% +$45.8K 0.18% 140
2024
Q1
$448K Buy
5,141
+239
+5% +$20.4K 0.18% 148
2023
Q4
$404K Buy
+4,902
New +$374K 0.18% 141

Other funds holding MDT

Fiduciary Family Office's MDT Position: Q2 2026 in Review

Fiduciary Family Office sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,333 shares — an estimated $375K sold.

Fiduciary Family Office first reported a position in MDT in Q4 2023 and held it in 9 quarters. The position peaked at $941K in Q3 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fiduciary Family Office reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Fiduciary Family Office sold 4,333 Medtronic shares in Q2 2026, an estimated $375K.
  • Fiduciary Family Office first reported a position in Medtronic in Q4 2023 and held it in 9 quarters.
  • Fiduciary Family Office's Medtronic position peaked at $941K in Q3 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.